Stabilization by lipid calcium phosphate nanoparticles (LCPs) has been shown to improve efficiency of an mRNA vaccine encoding gp100 and tyrosinase-related protein 2 (TRP-2) that was administered to immunocompetent murine B16F10 melanoma models. The gene discussed is PMEL; the disease is melanoma.